Archives of disease in childhood · 2026
Spotting childhood abdominal tumours: a systematic review and meta-analysis of the clinical presentation.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ni Cheallaigh Lorna, Liu Jo-Fen, Ball-Gamble Ashley, Walker David, Ritzmann Timothy A, Shanmugavadivel Dhurgshaarna
Аннотация
BACKGROUND: We performed a systematic review and meta-analysis to identify pre-diagnostic symptoms/signs for childhood abdominal tumours to inform ongoing efforts to achieve earlier diagnoses of childhood cancers.
METHODS: Medline (OVID), Embase (OVID) and PubMed were searched for studies published between January 2005 and December 2023, including children (<18 years) diagnosed with abdominal tumours, with no language restrictions. Pooled proportions of symptoms/signs were calculated. Sub-analyses were performed according to tumour location and age.
RESULTS: 133 eligible studies were identified, totalling 8611 cases. The most frequently reported symptoms/signs were abdominal mass (39.3% (31.5% to 47.5%)), pain (14.5 (10.9% to 18.5%), abdominal swelling/distension (7.2% (3.3% to 12.1%)), haematuria (7.2% (2.9% to 6.2%)), fever (3.9% (2.2% to 5.9%)) and/or hypertension (2.6% (1.4% to 4.2%)).For adrenal tumours, precocious puberty (20.6% (2.8% to 46.8%)), Cushing's syndrome (16.4% (5.9% to 30.1%)) and/or hypertension (12% (2.8% to 25.3%)) were reported.For liver tumours, abdominal mass (42.9% (0.0% to 100.0%)), abdomen mass and/or discomfort (16% (0.0% to 73.1%)), hepatomegaly (9.7% (0.0% to 60.7%)), abdominal swelling/distension (9.4% (0.0% to 64.0%)) and/or abdominal pain (7.7% (0.0% to 28.3%)) were reported.For renal tumours, abdominal mass (49.7% (39.0% to 60.5%)), abdominal pain (12.3% (8.5% to 16.6%)), haematuria (10% (7.4% to 13.0%)), abdominal swelling/distension (5.4% (1.5% to 11.2%)), hypertension (4.7% (2.5% to 7.5%)) and/or fever (3.5% (1.9% to 5.5%)) were reported.For neuroblastoma, abdominal mass (24% (7.0% to 46.4%), abdominal swelling/distension (9.2% (0.0% to 27.9%)), fever (7.4% (0.3% to 20.4%)), hepatomegaly (4.8% (0.0% to 19.8%)), anaemia/pallor (4.1% (0.0% to 13.3%)), abdominal pain (4% (0.0% to 13.4%)), screening/antenatal screening (3.4% (0.4% to 8.2%)) and/or opsoclonus-myoclonus-ataxia syndrome (2.7% (0.0% to 8.3%)) were reported.
CONCLUSIONS: The clinical presentation of childhood abdominal tumours varies according to location and tumour type. These variations in presentation should be used to guide interventions to facilitate earlier diagnosis, such as the UK's new Child Cancer Smart campaign.
METHODS: Medline (OVID), Embase (OVID) and PubMed were searched for studies published between January 2005 and December 2023, including children (<18 years) diagnosed with abdominal tumours, with no language restrictions. Pooled proportions of symptoms/signs were calculated. Sub-analyses were performed according to tumour location and age.
RESULTS: 133 eligible studies were identified, totalling 8611 cases. The most frequently reported symptoms/signs were abdominal mass (39.3% (31.5% to 47.5%)), pain (14.5 (10.9% to 18.5%), abdominal swelling/distension (7.2% (3.3% to 12.1%)), haematuria (7.2% (2.9% to 6.2%)), fever (3.9% (2.2% to 5.9%)) and/or hypertension (2.6% (1.4% to 4.2%)).For adrenal tumours, precocious puberty (20.6% (2.8% to 46.8%)), Cushing's syndrome (16.4% (5.9% to 30.1%)) and/or hypertension (12% (2.8% to 25.3%)) were reported.For liver tumours, abdominal mass (42.9% (0.0% to 100.0%)), abdomen mass and/or discomfort (16% (0.0% to 73.1%)), hepatomegaly (9.7% (0.0% to 60.7%)), abdominal swelling/distension (9.4% (0.0% to 64.0%)) and/or abdominal pain (7.7% (0.0% to 28.3%)) were reported.For renal tumours, abdominal mass (49.7% (39.0% to 60.5%)), abdominal pain (12.3% (8.5% to 16.6%)), haematuria (10% (7.4% to 13.0%)), abdominal swelling/distension (5.4% (1.5% to 11.2%)), hypertension (4.7% (2.5% to 7.5%)) and/or fever (3.5% (1.9% to 5.5%)) were reported.For neuroblastoma, abdominal mass (24% (7.0% to 46.4%), abdominal swelling/distension (9.2% (0.0% to 27.9%)), fever (7.4% (0.3% to 20.4%)), hepatomegaly (4.8% (0.0% to 19.8%)), anaemia/pallor (4.1% (0.0% to 13.3%)), abdominal pain (4% (0.0% to 13.4%)), screening/antenatal screening (3.4% (0.4% to 8.2%)) and/or opsoclonus-myoclonus-ataxia syndrome (2.7% (0.0% to 8.3%)) were reported.
CONCLUSIONS: The clinical presentation of childhood abdominal tumours varies according to location and tumour type. These variations in presentation should be used to guide interventions to facilitate earlier diagnosis, such as the UK's new Child Cancer Smart campaign.